Zidovudine therapy in thrombocytopenic human immunodeficiency virus-infected children
- PMID: 1749705
Zidovudine therapy in thrombocytopenic human immunodeficiency virus-infected children
Similar articles
-
Zidovudine therapy of HIV-associated thrombocytopenia: from MAIDS to AIDS.J Lab Clin Med. 1993 Apr;121(4):536-8. J Lab Clin Med. 1993. PMID: 8454934 No abstract available.
-
Lack of response of thrombocytopenia associated with human immunodeficiency virus to triple antiretroviral therapy.Arch Intern Med. 1997 Dec 8-22;157(22):2669-70. Arch Intern Med. 1997. PMID: 9580146 No abstract available.
-
Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).J Am Osteopath Assoc. 1996 Jun;96(6):339. J Am Osteopath Assoc. 1996. PMID: 8690619 No abstract available.
-
[HIV-related thrombocytopenias].Ann Ital Med Int. 2000 Jan-Mar;15(1):20-7. Ann Ital Med Int. 2000. PMID: 10842888 Review. Italian.
-
[Severe thrombocytopenia and human immunodeficiency virus infection. Report of two cases and review].Rev Chilena Infectol. 2007 Feb;24(1):63-7. Epub 2007 Mar 8. Rev Chilena Infectol. 2007. PMID: 17369974 Review. Spanish.
Cited by
-
Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1993 Sep;46(3):515-578. doi: 10.2165/00003495-199346030-00010. Drugs. 1993. PMID: 7693435 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical